Real-time quantitative PCR analysis of regions involved in gene amplification reveals gene overdose in low-grade astrocytic gliomas.
We have studied gene amplification of genes located in 1q32 (GAC1, ELF3, MDM4, and ren1), 4q11 (PDGFR-alpha), and in 12q13-14 (MDM2 and CDK4) using quantitative real-time PCR in a group of 86 tumors consisting of 44 WHO grade IV glioblastomas (GBM) (34 primary and 10 secondary tumors), 21 WHO grade III anaplastic astrocytomas (AA), and 21 WHO grade II astrocytomas (AII). Gene amplification was present in 56 of the 86 samples (65%) in at least 1 gene in our series. GAC1 (51%) and MDM4 (27%) were the most frequently amplified genes within the 1q32 amplicon, and their higher amplification frequency was statistically significant (P<0.05, chi) in the low-grade astrocytomas. Concordant co-amplification was determined for ELF3 and ren1 or ren1 and MDM4 in the grade III-IV tumors. MDM2 amplification was significantly more frequent in primary GBM (16%) than was in secondary GBM (0%). The present study shows that gene amplification in the studied regions is already present in low-grade astrocytic tumors and that amplification of some genes may represent another molecular marker to differentiate primary from secondary GBM.
Arjona
Dolores
D
Laboratorio Oncogenética Molecular, Unidad de Investigación, Hospital Universitario La Paz, Madrid, Spain.
Bello
M Josefa
MJ
Alonso
M Eva
ME
Isla
Alberto
A
De Campos
Jose M
JM
Vaquero
Jesus
J
Sarasa
Jose L
JL
Gutierrez
Manuel
M
Rey
Juan A
JA
D001254:Astrocytoma / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000032:analysis; D005784:Gene Amplification; D018628:Gene Dosage; D006801:Humans; D016133:Polymerase Chain Reaction; D011519:Proto-Oncogenes / Q000235:genetics*
D014408:Biomarkers, Tumor